Stay updated on Pembrolizumab in Recurrent HNSCC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Recurrent HNSCC Clinical Trial page.

Latest updates to the Pembrolizumab in Recurrent HNSCC Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision: v3.4.2 is now listed, replacing the previous v3.4.1. The site-wide notice about government operating status has been removed.SummaryDifference0.4%

- Check21 days agoChange DetectedA site-wide funding status notice was added, and the site revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check28 days agoChange DetectedThe page adds a glossary display and updates footer/version text (Last Update Submitted that Met QC Criteria; No FEAR Act Data; Revision: v3.4.0), replacing earlier lowercase variants and Revision: v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check41 days agoChange DetectedThe page revision tag was updated from v3.3.3 to v3.3.4; no visible changes to study data or content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedThe page now displays a new revision note 'Revision: v3.3.3' in the footer, and the 'HHS Vulnerability Disclosure' link along with the prior 'Revision: v3.3.2' note were removed.SummaryDifference0.1%

- Check85 days agoChange DetectedRevision label updated from v3.3.1 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in Recurrent HNSCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Recurrent HNSCC Clinical Trial page.